BioSpace News Archive

Strong year-over-year growth in revenue, net income, and earnings per share

HCP, Inc. announced that its Board of Directors declared a quarterly common stock cash dividend of $0.37 per share.

Revenue for the third quarter of 2018 was $40.8 million, a 30% increase compared to $31.5 million for the third quarter of 2017.

Johnson & Johnson today unveiled a new, state-of-the-art vaccines launch facility that represents a significant investment by the company in novel vaccines development, global health and security, and pandemic preparedness efforts

Aquestive Therapeutics, Inc. today announced that it will report results for the third quarter ended September 30, 2018 and provide a business update on Tuesday, November 6, 2018 after market close.

ADCETRIS® (Brentuximab Vedotin) Net Sales in U.S. and Canada of $127.0 Million in the Third Quarter

The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation awarded the 2018 Carestream Health/RSNA Research Scholar Grant to Christine E. Edmonds, M.D. This grant is made possible by Carestream Health’s support of the RSNA R&E Foundation.

Agilent Technologies Inc. today announced that it has been recognized by Forbes as one of the World’s Best Employers.

Precise Bio, a Regenerative Medicine company that is working on advancing the use of bio-printed tissues and organs to patients, announced today the launch of a dedicated ophthalmology business unit to support attainment of near-term opportunities in the ophthalmology arena as it builds a broad portfolio of programs in additional indications.

The increasing usage of electronic devices, changing lifestyle and hygiene have led to vision-related problems worldwide.